Holen Sie sich die Stockscreener-App
231.47
0.28%
0.64
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DHR?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$230.83
Offen:
$230.74
24-Stunden-Volumen:
785.81K
Relative Volume:
0.19
Marktkapitalisierung:
$163.50B
Einnahmen:
$24.27B
Nettoeinkommen (Verlust:
$3.50B
KGV:
47.64
EPS:
4.8589
Netto-Cashflow:
$5.02B
1W Leistung:
+3.97%
1M Leistung:
+1.98%
6M Leistung:
+17.22%
1J Leistung:
+0.31%
1-Tages-Spanne:
$229.79
$231.73
1-Wochen-Bereich:
$223.37
$231.73
52-Wochen-Spanne:
$171.00
$258.23
Danaher Corp Stock (DHR) Company Profile
Firmenname
Danaher Corp
Sektor
Branche
Telefon
(202) 828-0850
Adresse
2200 PENNSYLVANIA AVE. N.W., WASHINGTON, DC
Vergleichen Sie DHR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DHR
Danaher Corp
|
231.47 | 163.05B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
TMO
Thermo Fisher Scientific Inc
|
579.12 | 217.89B | 43.74B | 6.58B | 6.11B | 17.31 |
|
IDXX
Idexx Laboratories Inc
|
688.18 | 54.48B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
138.32 | 39.22B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
226.02 | 38.34B | 15.90B | 1.28B | 2.21B | 7.2842 |
Danaher Corp Stock (DHR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Goldman | Buy |
| 2025-12-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-10-08 | Herabstufung | Rothschild & Co Redburn | Buy → Neutral |
| 2025-07-11 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-04-10 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-03-21 | Hochstufung | Goldman | Neutral → Buy |
| 2025-03-14 | Hochstufung | Stifel | Hold → Buy |
| 2025-02-03 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-12-23 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-12-19 | Eingeleitet | Guggenheim | Buy |
| 2024-12-13 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-10-31 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2024-10-01 | Eingeleitet | Stephens | Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-04-17 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-01-24 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2023-12-18 | Eingeleitet | HSBC Securities | Hold |
| 2023-12-13 | Fortgesetzt | Wolfe Research | Peer Perform |
| 2023-12-07 | Herabstufung | Goldman | Buy → Neutral |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-05-01 | Eingeleitet | SVB Securities | Outperform |
| 2023-04-26 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-04-18 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-01-05 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-10-24 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-08-17 | Fortgesetzt | Bernstein | Outperform |
| 2022-07-20 | Eingeleitet | UBS | Buy |
| 2022-06-01 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-01-11 | Eingeleitet | Bernstein | Outperform |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-09-10 | Bestätigt | BofA Securities | Buy |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-23 | Bestätigt | Goldman | Buy |
| 2021-07-16 | Eingeleitet | The Benchmark Company | Buy |
| 2021-04-07 | Fortgesetzt | Robert W. Baird | Outperform |
| 2021-03-03 | Fortgesetzt | Barclays | Overweight |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-25 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-06-16 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-04-02 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-03-26 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-02-03 | Bestätigt | Needham | Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Fortgesetzt | Stifel | Hold |
| 2019-10-28 | Bestätigt | Needham | Buy |
| 2019-10-14 | Fortgesetzt | Credit Suisse | Outperform |
| 2019-07-19 | Bestätigt | Needham | Buy |
| 2019-06-11 | Eingeleitet | Piper Jaffray | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2019-04-17 | Bestätigt | Needham | Buy |
| 2019-02-28 | Bestätigt | Needham | Buy |
| 2019-02-25 | Hochstufung | Janney | Neutral → Buy |
| 2019-01-03 | Eingeleitet | Needham | Buy |
| 2018-04-20 | Bestätigt | Stifel | Buy |
Alle ansehen
Danaher Corp Aktie (DHR) Neueste Nachrichten
Danaher (DHR) Stock After Hours on Dec. 24, 2025: What Happened After the Early Close — and What to Know Before the Next Market Open - ts2.tech
HALPER SADEH LLC ENCOURAGES DANAHER CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - Finviz
Ex-Dividend Reminder: Medtronic, Danaher and DENTSPLY SIRONA - Nasdaq
James Hambro & Partners LLP Lowers Stock Holdings in Danaher Corporation $DHR - MarketBeat
Swedbank AB Reduces Stock Position in Danaher Corporation $DHR - MarketBeat
DAVENPORT & Co LLC Has $133.51 Million Position in Danaher Corporation $DHR - MarketBeat
Danaher Corp. stock outperforms competitors on strong trading day - MarketWatch
Best Biotech Stocks Worth WatchingDecember 18th - MarketBeat
Riverbridge Partners LLC Has $49.61 Million Stock Holdings in Danaher Corporation $DHR - MarketBeat
CCLA Investment Management Increases Holdings in Danaher Corporation $DHR - MarketBeat
Danaher Corporation $DHR is Arthur M. Cohen & Associates LLC's 6th Largest Position - MarketBeat
Zacks Research Has Strong Estimate for Danaher Q4 Earnings - MarketBeat
Goldman Sachs and KeyBanc are Bullish on Danaher (DHR) - Yahoo Finance
2025-12-21 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Danaher Corporation (DHR) and Encourages Shareholders to Learn More About the Investigation | NYSE:DHR | Press Release - Stockhouse
Goldman Sachs and KeyBanc are bullish on Danaher (DHR) - MSN
Foster Victor Wealth Advisors LLC Has $19.71 Million Stock Position in Danaher Corporation $DHR - MarketBeat
Douglas Lane & Associates LLC Acquires 73,352 Shares of Danaher Corporation $DHR - MarketBeat
Danaher (DHR): Revisiting Valuation as Earnings Grow While the Share Price Stalls - simplywall.st
Promising Biotech Stocks To Watch NowDecember 14th - MarketBeat
Danaher (NYSE:DHR) shareholders have endured a 0.9% loss from investing in the stock three years ago - Yahoo Finance
Louisbourg Investments Inc. Invests $4.26 Million in Danaher Corporation $DHR - MarketBeat
Aaron Wealth Advisors LLC Lowers Position in Danaher Corporation $DHR - MarketBeat
Voya Investment Management LLC Has $219.39 Million Stake in Danaher Corporation $DHR - MarketBeat
Phraction Management LLC Acquires 18,620 Shares of Danaher Corporation $DHR - MarketBeat
Montecito Bank & Trust Takes Position in Danaher Corporation $DHR - MarketBeat
Zacks Research Analysts Cut Earnings Estimates for Danaher - MarketBeat
Osaic Holdings Inc. Increases Position in Danaher Corporation $DHR - MarketBeat
Bath Savings Trust Co Sells 5,777 Shares of Danaher Corporation $DHR - MarketBeat
Will Strength in Biotechnology Unit Continue to Drive Danaher's Growth? - The Globe and Mail
KeyBanc reiterates Overweight rating on Danaher stock, sees M&A potential - Investing.com
What macro factors could drive Danaher Corporation stock higherJuly 2025 Technicals & Growth Focused Entry Reports - Улправда
Marathon Petroleum (MPC) appoints Maria Khoury as new CFO effective 2026 - Stock Titan
Thurston Springer Miller Herd & Titak Inc. Cuts Position in Danaher Corporation $DHR - MarketBeat
Top Biotech Stocks To ConsiderDecember 15th - MarketBeat
Danaher Corporation $DHR Stock Holdings Decreased by Fiduciary Alliance LLC - MarketBeat
Danaher Corporation $DHR Shares Bought by Czech National Bank - MarketBeat
Dudley & Shanley Inc. Has $22.79 Million Stake in Danaher Corporation $DHR - MarketBeat
Danaher (NYSE:DHR) Price Target Raised to $255.00 - MarketBeat
ST Germain D J Co. Inc. Acquires 56,547 Shares of Danaher Corporation $DHR - MarketBeat
Danaher Schedules Fourth Quarter 2025 Earnings Conference Call - Yahoo Finance
Danaher Corporation $DHR Stock Position Lifted by Fragasso Financial Advisors Inc - MarketBeat
Danaher Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Promising Biotech Stocks To Follow TodayDecember 11th - MarketBeat
Is It Time To Consider Buying Danaher Corporation (NYSE:DHR)? - Yahoo Finance
Texas Permanent School Fund Corp Reduces Holdings in Danaher Corporation $DHR - MarketBeat
Industrial Stocks To ResearchDecember 13th - MarketBeat
Caldwell Trust Co Acquires Shares of 4,805 Danaher Corporation $DHR - MarketBeat
Top Biotech Stocks To Add to Your WatchlistDecember 12th - MarketBeat
Advisory Services Network LLC Decreases Stake in Danaher Corporation $DHR - MarketBeat
Danaher Stock (DHR) News Today: BofA Lifts Price Target to $265, Wells Fargo to $240 as 2026 Normalization Comes Into Focus - ts2.tech
Wells Fargo Adjusts Price Target for Danaher (DHR) to $240 | DHR Stock News - GuruFocus
Finanzdaten der Danaher Corp-Aktie (DHR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.14%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):